Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
Marco Rubatto, Paolo Fava, Ignazio Stanganelli, Simone Ribero, Jacopo Pigozzo, Anna Maria Di Giacomo, Laura Ridolfi, Maria Chiara Tronconi, Claudia Trojaniello, Melissa Bersanelli, Mattia Garutti, Alice Indini, Ivana De Risi, Michele De Tursi, Barbara Merelli, Francesca Morgese, Marcella Occelli, Gian Carlo Antonini Cappellini, Stefano Poletto, D. Fedele, Sonia Brugnara, M. Frisinghelli, Luigi Formisano, Raffaele Conca, Marco Tucci, Michelangelo Russillo, Luca Ceroni, Paola Queirolo, Giada Targato, Sabino Strippoli, Mario Mandalà, Michele Guida, Pietro Quaglino
Topics & Concepts
MedicineDiscontinuationMelanomaInternal medicineAdverse effectImmunotherapyRetrospective cohort studyPopulationSurgeryOncologyCancerEnvironmental healthCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways